4199 |
Which Patients with Stable CAD Benefit from PCI in the Post-ISCHEMIA Era? |
Gregg W. Stone |
Apr. 08. 22 |
4198 |
OMT Is Always the Default Choice |
David J. Maron |
Apr. 08. 22 |
4197 |
Lower for Longer: Effective Lipid Lowering – Rising on Ezetimibe Therapy |
Gyu-Chul Oh |
Apr. 08. 22 |
4196 |
Early for Longer: Intensive Lipid Lowering - Moving Beyond Statins Alone |
Dong-Bin Kim |
Apr. 08. 22 |
4195 |
MASTER DAPT Study Design and Clinical Findings |
Fazila Malik |
Apr. 08. 22 |
4194 |
Sizing and Treatment of Low Risk Bicuspid Patient |
Didier Tchetche |
Apr. 08. 22 |
4193 |
Post TAVR PCI |
Young-Guk Ko |
Apr. 08. 22 |
4192 |
Challenging Case: Simultaenous TMVr with MitraClip & TAVR in a Patient |
Seung Yong Lee |
Apr. 08. 22 |
4191 |
Optimal Valve Choice in TAVR |
|
Apr. 08. 22 |
4190 |
STEMI with MVD; How Can We Treat Non-Culplit Lesion. Revacularization is Needed? |
Sang Man Park |
Apr. 08. 22 |